UFP Technologies Inc. Reports Impressive Growth in 2024 Annual Report
UFP Technologies Inc., a leading designer and custom manufacturer of solutions for the medical device sector, has released its annual report for 2024, showcasing remarkable financial performance and strategic growth initiatives. The company's commitment to innovation and quality has positioned it as a vital partner in the medical device supply chain.
1. Company Overview
Founded in 1993, UFP Technologies specializes in producing highly engineered custom products primarily for the medical, automotive, aerospace, and industrial markets. In 2024, the company continued to strengthen its market position through strategic acquisitions and organic growth, achieving a significant 26.1% increase in net sales.
2. Financial Highlights
Revenue Growth
UFP Technologies reported net sales of $504.4 million for the fiscal year ending December 31, 2024, compared to $400.1 million in 2023. This impressive growth was fueled by a robust 30.2% increase in net sales within the medical market, making it a cornerstone of the company's revenue stream. Medical sales represented 89.4% of total net sales in 2024.
Operating and Net Income
The company also saw a substantial increase in profitability, with operating income climbing 40.3% to $143.8 million and net income rising 31.3% to $114.8 million. The gross margin improved to 29.1%, reflecting enhanced operational efficiencies and cost management strategies.
| Feb 2024 | Mar 2025 | |
|---|---|---|
Net Income | 44.92M | 58.98M |
Profit | 44.92M | 58.98M |
Net Income Continuing | 44.92M | 58.98M |
Income Tax Expense | 8.97M | 14.04M |
Pretax Income | 53.90M | 73.02M |
Non-operating Income | -3.76M | -7.87M |
Operating Income | 57.66M | 80.89M |
Revenue | 400.0M | 504.4M |
Costs and Expenses | 342.4M | 423.5M |
Cost of Revenue | 287.8M | 357.7M |
Operating Expenses | 54.56M | 65.79M |
Selling, General & Administrative | 50.88M | 62.21M |
Other Operating Expenses | 3.67M | 3.57M |
Revenue by Product and Major Customers
In terms of revenue by products or services, the breakdown is as follows:
- Engineering and Development: $4.71 million (down 8.26% from 2023)
- Tooling and Machinery: $8.32 million (up 139.91% from 2023)
- Product Sales: $491.3 million (up 25.53% from 2023)
Revenue from major customers illustrated a similar trend, with medical sales leading:
- Medical: $450.7 million (up 30.15% from 2023)
- Industrial: $18.13 million (down 9.43%)
- Automotive: $15.09 million (down 9.6%)
- Aerospace & Defense: $20.41 million (up 20.18%)
3. Strategic Acquisitions
A pivotal aspect of UFP Technologies' growth strategy in 2024 was the completion of four strategic acquisitions, including Marble Medical, AJR Enterprises, Welch Fluorocarbon, and AQF Medical. These acquisitions primarily serve the medical market and are expected to enhance the company's product offerings and market reach.
4. Financial Position
UFP Technologies' balance sheet reflects its growth trajectory, with total assets increasing to $622.3 million in 2024 from $398.3 million in 2023. The company's equity also rose to $342.7 million, supported by retained earnings of $306.5 million.
| Feb 2024 | Mar 2025 | |
|---|---|---|
Total Assets | 398.3M | 622.3M |
Total Current Assets | 144.6M | 194.9M |
Cash and Equivalents | 5.26M | 13.45M |
Net Inventories | 70.19M | 87.53M |
Accounts Receivable | 64.44M | 84.67M |
Non-trade Receivables | 1.29M | 4.97M |
Prepaid Expenses | 3.43M | 4.30M |
Total Non-current Assets | 253.7M | 427.4M |
Intangible Assets | 177.3M | 333.9M |
Long-term Investments | 0 | 6.80M |
Non-current Deferred Tax Assets | 607K | 0 |
Net PP&E | 62.13M | 70.56M |
Lease Assets | 13.58M | 16.14M |
Total Liabilities and Equity | 404.1M | 628.9M |
Total Liabilities | 118.0M | 286.2M |
Total Current Liabilities | 58.20M | 76.29M |
Accounts Payable and Accrued Liabilities | 44.37M | 54.90M |
Current Debt | 7.22M | 16.72M |
Current Deferred Revenue | 6.61M | 4.66M |
Total Non-current Liabilities | 59.83M | 209.9M |
Long-term Debt | 28M | 176.8M |
Non-current Deferred Compensation | 5.4M | 6.2M |
Non-current Deferred Tax Liabilities | 428K | 3.29M |
Other Non-current Liabilities | 26.00M | 23.56M |
Total Equity and Non-controlling Interests | 286.0M | 342.7M |
Total Equity | 286.0M | 342.7M |
5. Cash Flow and Liquidity
In terms of liquidity, UFP Technologies generated approximately $66.6 million in net cash from operations. This strong cash flow supports the company's capital requirements, growth plans, and operational expenses. The company maintains a secured term loan of $125 million and a revolving credit facility of up to $150 million, with total borrowings of $189.4 million as of December 31, 2024.
| Feb 2024 | Mar 2025 | |
|---|---|---|
Net Change in Cash | 812K | 8.18M |
Effect of Exchange Rate Changes | -10K | -635K |
Net Cash from Operating Activities | 41.33M | 66.59M |
Operating Profit | 44.92M | 58.98M |
Adjustment to Operating Profit | -3.59M | 7.61M |
Net Cash from Investing Activities | -10.48M | -210.1M |
Business & Interest in Affiliates | 0 | 197.4M |
Productive Assets | 10.48M | 9.63M |
Other Investing Activities | 0 | -3.05M |
Net Cash from Financing Activities | -30.02M | 152.3M |
Debt | -23.06M | 157.3M |
Equity Issuance/Repurchase | 680K | 233K |
Other Financing Activities | -7.64M | -5.14M |
6. Challenges and Legal Proceedings
Despite the stellar performance, UFP Technologies incurred approximately $2.5 million in costs associated with acquisition-related activities and recorded a $1.0 million expense related to changes in fair value of contingent considerations. The company is also involved in a single employee claim; however, management believes that this will not materially affect its financial standing.
7. Conclusion
UFP Technologies Inc. has demonstrated robust growth and resilience in 2024, significantly enhancing its market position in the medical device sector. With strategic acquisitions and a focus on innovation, the company is well-positioned for continued success in the coming years. As it moves forward, UFP Technologies remains committed to delivering high-quality, engineered solutions that meet the evolving needs of its diverse clientele.
